Paraneoplastic syndromes in 68 cases of resectable non-small cell lung carcinoma: can they help in early detection?

被引:16
|
作者
Campanella, N
Moraca, A
Pergolini, M
Daher, W
Fianchini, A
Sabbatini, A
Brunelli, A
Al-Refai, M
机构
[1] Umberto I Torrette Reg Hosp, Med Pathol Inst, Ancona, Italy
[2] Univ Ancona, Dept Thorac Surg, Ancona, Italy
关键词
paraneoplastic syndromes; lung; cancer; bronchogenic; prevalence; non-small cell lung carcinoma; early diagnosis;
D O I
10.1007/BF02785846
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of this study was to assess the importance of paraneoplastic syndromes as an early sign of non-small cell lung cancer (NSCLC). A procedure for searching paraneoplastic syndromes, based on 40 years of reports in the literature, was established and the prevalence of paraneoplastic syndromes estimated in 68 patients with resectable NSCLC. Stages I and II were considered eligible for surgery straight away. Patients in Stage IIIA underwent surgery if partially or completely responsive to three courses of neo-adjuvant chemotherapy, Paraneoplastic syndromes were assessed and confirmed in nine patients (13%). Motor-sensory neuropathy, arthritis and arthralgias to the knees, periarthritis to the shoulder, hypertrophic osteopathy, clubbing, pruritus were observed, Only three patients with painful osteoarthropathies were diagnosed with NSCLC by tracing their paraneoplastic syndrome, whereas most of them (36/68) were diagnosed incidentally through a chest radiograph taken for tumour-unrelated symptoms. A careful research of paraneoplastic syndromes in high risk patients may guide the doctor to a resectable NSCLC diagnosis. Recent onset arthritis and arthralgias, which cannot be explained otherwise, should be considered to be early clues of lung cancer.
引用
收藏
页码:129 / 133
页数:5
相关论文
共 50 条
  • [21] Paraneoplastic pandysautonomia as a manifestation of non-small cell lung cancer
    Kayihan Uluc
    Muge Kocak
    Pinar Kahraman Koytak
    Deniz Borucu
    Baris Isak
    Sevinc Aktan
    Onder Us
    Neurological Sciences, 2010, 31 : 813 - 816
  • [22] Paraneoplastic pandysautonomia as a manifestation of non-small cell lung cancer
    Uluc, Kayihan
    Kocak, Muge
    Koytak, Pinar Kahraman
    Borucu, Deniz
    Isak, Bans
    Aktan, Sevinc
    Us, Onder
    NEUROLOGICAL SCIENCES, 2010, 31 (06) : 813 - 816
  • [23] A Paradigm Shift for Resectable Non-Small Cell Lung Cancer
    Isla, Dolores
    Majem, Margarita
    ARCHIVOS DE BRONCONEUMOLOGIA, 2022, 58 (12): : 792 - 793
  • [24] Adjuvant treatment for resectable non-small cell lung cancer
    Lim, Jeong Uk
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2023, 66 (03): : 173 - 179
  • [25] Immunotherapy in surgically resectable non-small cell lung cancer
    Owen, Dwight
    Chaft, Jamie E.
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S404 - S411
  • [26] Prognostic markers in resectable non-small cell lung cancer
    Strauss, GM
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1997, 11 (03) : 409 - &
  • [27] Neoadjuvant chemotherapy for resectable non-small cell lung cancer
    Finkelstein, EI
    Urschel, JD
    Takita, H
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 1997, 16 (04) : 437 - 439
  • [28] Neoadjuvant immunotherapy for resectable non-small cell lung cancer
    Xie, Hui
    Shi, Xuejun
    Wang, Guangshun
    AMERICAN JOURNAL OF CANCER RESEARCH, 2021, 11 (06): : 2521 - 2536
  • [29] Neoadjuvant Immunotherapy in Resectable Non-Small Cell Lung Cancer
    Lochrin, Sarah E.
    Forde, Patrick M.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2023, 21 (08) : 415 - 423
  • [30] Resectable non-small cell lung cancer: an evolving landscape
    Loh, Jerold
    Wijaya, Silvana T.
    Sooi, Kenneth
    Chia, Puey Ling
    Soo, Ross A.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2022, 11 (07) : 1241 - 1246